Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
Latest reports on cell and gene therapy clinical trials and preclinical programmes indicate the industry in the UK is progressing
A pioneering new company based on Selvita research and utilising novel immunological approaches to disease
As analytical methods provide data crucial to ensure consumer health and safety, their validation is highly scrutinised. Dr Joanna Greenhough, R&D Scientist, Wickham Laboratories, outlines the best practices in validating methods used in pharmaceutical product testing
Company certified to produce pharmaceutical grade lanolin
More than 80% of surveyed pharmaceutical companies begin their new product launch sequences in the world's largest drug market.
Robert Gaertner from Veeva Systems makes the case that cloud-based collaboration increases productivity and transparency, and reduces quality risks in the life sciences supply chain
Phase III clinical trials of tildrakizumab were completed in May, with positive results
A great opportunity for businesses to get their brand, products and equipment in front of a high profile audience and celebrate the innovation that the industry has to offer
Teva expects the cash and stock deal to go ahead next week
Antibody-drug conjugates could hold the key to delivering highly potent anticancer drugs more accurately to the tumour site with less damage to healthy cells
Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will spend $350 million over the next five years
In this second article of a two-part series, John Farris, CIH, and Robert Sussman, PhD DABT, SafeBridge Consultants, cover the safe handling of antibody-drug conjugates in pharmaceutical facilities and the control measures needed to protect workers from exposure risks